Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 701–800 of 1,008
Epithelial-Stromal Interactions in Pancreatic Cancer
Zhang, Y., Crawford, H. C., & Pasca di Magliano, M. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114515 · Cited by 49
Hao, J., Zeltz, C., Pintilie, M., Li, Q., Sakashita, S., Wang, T., Cabanero, M., Martins-Filho, S. N., Wang, D. Y. Q., Pasko, E., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.03.009 · Cited by 51
Fang, Z., Xu, J., Zhang, B., Wang, W., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00988-x · Cited by 49
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
Vonderheide, R. H., & Bear, A. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605619 · Cited by 54
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
Garcia, P. E., Scales, M. K., Allen, B. L., & Pasca di Magliano, M. (2020) · Cells · doi:10.3390/cells9112464 · Cited by 48
Tumour microenvironment 3D-modelling: simplicity to complexity and back again
Carter, E. P., Roozitalab, R., Gibson, S. V., & Grose, R. P. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.06.009 · Cited by 52
Ding, L., Fu, Y., Zhu, N., Zhao, M., Ding, Z., Zhang, X., Song, Y., Jing, Y., Zhang, Q., Chen, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32787-y · Cited by 57
Silva, I. D. C., Bianchi, A., Deshpande, N., Sharma, P., Mehra, S., Garrido, V. T., Saigh, S. J., England, J. S., Hosein, P. J., Kwon, D., et al. (2022) · eLife · doi:10.7554/elife.78921 · Cited by 50
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
Fang, B., Lu, Y., Li, X., Yu, W., Ye, D., Wei, G., & Zhu, Y. (2024) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-024-00825-z · Cited by 61
Man, Y. K. S., Davies, J. A., Coughlan, L., Pantelidou, C., Blázquez-Moreno, A., Marshall, J. F., Parker, A. L., & Halldén, G. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0671 · Cited by 50
Interferon Lambda: Toward a Dual Role in Cancer
Lasfar, A., Zloza, A., Silk, A. W., Lee, L. Y., & Cohen-Solal, K. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0046 · Cited by 48
Li, B., Pei, G., Yao, J., Ding, Q., Jia, P., & Zhao, Z. (2021) · Oncogene · doi:10.1038/s41388-021-01870-x · Cited by 52
Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
Elwakeel, E., & Weigert, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111636 · Cited by 53
Fotsitzoudis, C., Koulouridi, A., Messaritakis, I., Konstantinidis, T., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2022) · Cancers · doi:10.3390/cancers14184394 · Cited by 46
Gorchs, L., & Kaipe, H. (2021) · Cancers · doi:10.3390/cancers13122995 · Cited by 64
HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation
Chia, L., Wang, B., Kim, J., Luo, L., Shuai, S., Herrera, I., Chen, S. Y., Li, L., Xian, L., Huso, T. H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci151601 · Cited by 57
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 53
Guinn, S. R., Kinny‐Köster, B., Tandurella, J. A., Mitchell, J. T., Sidiropoulos, D. N., Loth, M., Lyman, M. R., Pucsek, A. B., Zabransky, D. J., Lee, J. W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1660 · Cited by 51
Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer
Huang, H., & Brekken, R. A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00079.2020 · Cited by 50
Vaes, R. D. W., van Dijk, D. P. J., Welbers, T. T. J., Blok, M. J., Aberle, M. R., Heij, L. R., Boj, S. F., Damink, S. W. M. O., & Rensen, S. S. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12627 · Cited by 49
Abe, H., Tanada, Y., Omiya, S., Podaru, M., Murakawa, T., Ito, J., Shah, A. M., Conway, S. J., Ono, M., & Otsu, K. (2021) · Science Signaling · doi:10.1126/scisignal.abe4932 · Cited by 48
Living biobank-based cancer organoids: prospects and challenges in cancer research
Li, H., Liu, H., & Chen, K. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0621 · Cited by 54
Duan, Y., Zhang, X., Ying, H., Xu, J., Yang, H., Sun, K., He, L., Li, M., Ji, Y., Liang, T., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02711-9 · Cited by 53
Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
Carvalho, P. D., Machado, A. L., Martins, F., Seruca, R., & Velho, S. (2019) · Cancers · doi:10.3390/cancers11122010 · Cited by 51
Organoids from the Human Fetal and Adult Pancreas
Balak, J. R. A., Juksar, J., Carlotti, F., Nigro, A. L., & de Koning, E. J. P. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1261-z · Cited by 51
Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
Sempere, L. F., Powell, K., Rana, J., Brock, A. A., & Schmittgen, T. D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09995-x · Cited by 49
Liabeuf, D., Oshima, M., Stange, D. E., & Sigal, M. J. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.12.252 · Cited by 49
Group Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 55
Ritter, A., Kreis, N., Roth, S., Friemel, A., Safdar, B. K., Hoock, S. C., Wildner, J. M., Allert, R., Louwen, F., Solbach, C., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02592-y · Cited by 47
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Kung, H., & Yu, J. (2023) · MedComm · doi:10.1002/mco2.216 · Cited by 46
Identification of cancer-associated fibroblasts subtypes in prostate cancer
Pan, J., Ma, Z., Лю, Б., Qian, H., Shao, X., Liu, J., Wang, Q., & Xue, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133160 · Cited by 50
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers
Korbecki, J., Bosiacki, M., Barczak, K., Łagocka, R., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · Cells · doi:10.3390/cells12101406 · Cited by 52
Flourishing tumor organoids: History, emerging technology, and application
Yang, Q., Li, M., Yang, X., Xiao, Z., Tong, X., Tuerdi, A., Li, S., & Lei, L. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10559 · Cited by 48
Skin fibroblast functional heterogeneity in health and disease
Bensa, T., Tekkela, S., & Rognoni, E. (2023) · The Journal of Pathology · doi:10.1002/path.6159 · Cited by 53
Guo, J., Wang, S., & Gao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258538 · Cited by 53
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 55
Singh, S. P., Dosch, A. R., Mehra, S., Silva, I. D. C., Bianchi, A., Garrido, V. T., Zhou, Z., Adams, A. M., Amirian, H., Box, E. W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1200 · Cited by 50
Li, P., Zhang, H., Chen, T., Zhou, Y., Yang, J., & Zhou, J. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.06.004 · Cited by 53
Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
Bhattacharyya, S., Oon, C. H., Kothari, A., Horton, W. R., Link, J. M., Sears, R. C., & Sherman, M. H. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191805 · Cited by 49
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
Everts, A., Bergeman, M. H., McFadden, G., & Kemp, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110474 · Cited by 49
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
García-Sampedro, A., Gaggia, G., Ney, A., Mahamed, I., & Acedo, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040566 · Cited by 50
Tahkola, K., Ahtiainen, M., Mecklin, J., Kellokumpu, I., Laukkarinen, J., Tammi, M., Tammi, R., Väyrynen, J. P., & Böhm, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91796-x · Cited by 51
The Extracellular Matrix: Composition, Function, Remodeling and Its Role in TumorigenesisPreprint
Dzobo, K., & Dandara, C. (2023) · Preprints.org · doi:10.20944/preprints202301.0555.v1 · Cited by 45
Zou, R., Jiang, Q., Jin, T., Chen, M., Yao, L., & Ding, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956224 · Cited by 47
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 53
Proline metabolism shapes the tumor microenvironment: from collagen deposition to immune evasion
Kay, E. J., Zanivan, S. R., & Rufini, A. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.103011 · Cited by 53
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Chakkera, M., Foote, J. B., Farran, B., & Nagaraju, G. P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189065 · Cited by 58
The Next Wave of Stroma-Targeting Therapy in Pancreatic Cancer
Huang, H., & Brekken, R. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3751 · Cited by 44
Singh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 46
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 50
The role of PARP inhibitors in BRCA mutated pancreatic cancer
Chi, J., Chung, S. Y., Parakrama, R. Y., Fayyaz, F., Jose, J., & Saif, M. W. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211014818 · Cited by 54
A glitch in the matrix: organ-specific matrisomes in metastatic niches
Deasy, S. K., & Erez, N. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.001 · Cited by 45
Drivers of transcriptional variance in human intestinal epithelial organoids
Criss, Z. K., Bhasin, N., Rienzi, S. C. D., Rajan, A., Deans-Fielder, K., Swaminathan, G., Kamyabi, N., Zeng, X., Doddapaneni, H., Menon, V. K., et al. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00061.2021 · Cited by 45
Wang, J., Chen, C., Wang, L., Xie, M., Ge, X., Wu, S., He, Y., Mou, X., Ye, C., & Sun, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.872531 · Cited by 52
Hinzman, C. P., Singh, B. B., Bansal, S., Li, Y., Iliuk, A. B., Girgis, M. J., Herremans, K. M., Trevino, J. G., Singh, V. K., Banerjee, P. P., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12232 · Cited by 49
Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance
Popovic, A., & Tartare‐Deckert, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924553 · Cited by 50
Emerging diversity in extracellular vesicles and their roles in cancer
Sohal, I. S., & Kasinski, A. L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1167717 · Cited by 49
Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling
de Barros, N. R., Gomez, A., Ermis, M., Falcone, N., Haghniaz, R., Young, P., Gao, Y., Aquino, A.-F., Li, S., Niu, S., et al. (2023) · Biofabrication · doi:10.1088/1758-5090/ace0db · Cited by 49
Xu, W., Cai, J., Tianxing, P., Meng, T., Pang, Y., Sun, L., Wu, H., Zhang, J., Chen, X. S., & Chen, H. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266329 · Cited by 43
Fu, Y., Tao, J., Liu, T., Liu, Y., Qiu, J., Su, D., Wang, R., Luo, W., Cao, Z., Weng, G., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02050-7 · Cited by 51
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Veghini, L., Pasini, D., Fang, R., Delfino, P., Filippini, D., Neander, C., Vicentini, C., Fiorini, E., Lupo, F., D’Agosto, S. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54975-8 · Cited by 53
Self-citationParacrine and cell autonomous signalling in pancreatic cancer progression and metastasis
Thomas, S. K., Lee, J., & Beatty, G. L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102662 · Cited by 47
In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids
Devarasetty, M., Forsythe, S. D., Shelkey, E., & Söker, S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00258-4 · Cited by 51
T-Cell Immunity in Pancreatic Cancer
Ajina, R., & Weiner, L. M. (2020) · Pancreas · doi:10.1097/mpa.0000000000001621 · Cited by 50
Hydrogels to engineer tumor microenvironments in vitro
Fernando, K., Kwang, L. G., Lim, J. T. C., & Fong, E. L. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01943g · Cited by 47
Croft, W. D., Pearce, H., Margielewska‐Davies, S., Lim, L., Nicol, S. M., Zayou, F., Blakeway, D., Marcon, F., Powell-Brett, S. F., Mahon, B. S., et al. (2023) · eLife · doi:10.7554/elife.86125 · Cited by 48
Cornwell, A. C., Tisdale, A. A., Venkat, S., Maraszek, K. E., Alahmari, A. A., George, A. M., Attwood, K. M., George, M., Rempinski, D., Franco‐Barraza, J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0547 · Cited by 44
Spektor, A.-M., Gutjahr, E., Lang, M., Glatting, F. M., Hackert, T., Pausch, T. M., Tjaden, C., Schreckenberger, M., Haberkorn, U., & Röhrich, M. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266393 · Cited by 45
Xia, G., Zhang, H., Cheng, R., Wang, H., Song, Z., Deng, L., Huang, X., Santos, H. A., & Cui, W. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800593 · Cited by 43
Ishii, N., Araki, K., Yokobori, T., Hagiwara, K., Gantumur, D., Yamanaka, T., Handa, T., Tsukagoshi, M., Igarashi, T., Watanabe, A., et al. (2018) · Cancer Science · doi:10.1111/cas.13847 · Cited by 44
Zou, B., Liu, X., Gong, Y., Cai, C., Li, P., Xing, S., Pokhrel, B., Zhang, B., & Li, J. (2018) · Cancer Management and Research · doi:10.2147/cmar.s176152 · Cited by 44
Kimura, T., Monslow, J., Klampatsa, A., Leibowitz, M. S., Sun, J., Liousia, M., Woodruff, P., Moon, E. K., Todd, L., Puré, E., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2019 · Cited by 49
Precision medicine in pancreatic cancer: treating every patient as an exception
Herbst, B. T., & Zheng, L. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30175-x · Cited by 47
Deconstructing tumor heterogeneity: the stromal perspective
Vickman, R. E., Faget, D. V., Beachy, P., Beebe, D., Bhowmick, N. A., Cukierman, E., Deng, W.-M., Granneman, J. G., Hildesheim, J., Kalluri, R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27736 · Cited by 42
Self-citationYu, Y., Yang, G., Huang, H., Fu, Z., Cao, Z., Zheng, L., You, L., & Zhang, T. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01787-5 · Cited by 48
Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02301-9 · Cited by 41
Diwanji, R., O’Brien, N. A., Choi, J. E., Nguyen, B., Laszewski, T., Grauel, A. L., Yan, Z., Xu, X., Wu, J., Ruddy, D. A., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0290 · Cited by 47
Shi, Z., Sun, Z., Zhu, Z., Liu, X., Chen, J., Hao, L., Zhu, J., Pang, K., Wu, D., Dong, Y., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1338 · Cited by 43
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies
He, K., Wang, Z., Luo, M., Li, B., Ding, N., Li, L., He, B., Wang, H., Cao, J., Huang, C., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04460-5 · Cited by 54
Storrs, E. P., Chati, P., Usmani, A., Sloan, I. H., Krasnick, B. A., Babbra, R. K., Harris, P. K. W., Sachs, C. M., Qaium, F., Chatterjee, D., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00455-z · Cited by 53
Serrated colorectal cancer: preclinical models and molecular pathways
Aiderus, A., Barker, N., & Tergaonkar, V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.09.011 · Cited by 55
Ravi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 47
Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer
Chen, Y., Liang, Z., & Lai, M. (2024) · Translational research · doi:10.1016/j.trsl.2024.04.003 · Cited by 48
Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution
Martínez‐Hernández, R., de la Blanca, N. S., Sacristan-Gomez, P., Serrano-Somavilla, A., de Nova, J. L. M., Sánchez‐Cabo, F., Heyn, H., Sampedro-Nuñez, M. A., & Marazuela, M. (2024) · Nature Communications · doi:10.1038/s41467-024-50192-5 · Cited by 53
Mundry, C. S., Eberle, K. C., Singh, P. K., Hollingsworth, M. A., & Mehla, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188387 · Cited by 44
Kato, H., Naiki‐Ito, A., Suzuki, S., Inaguma, S., Komura, M., Nakao, K., Naiki, T., Kachi, K., Kato, A., Matsuo, Y., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab017 · Cited by 41
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
Polani, F., Grierson, P. M., & Lim, K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i18.2105 · Cited by 49
Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis
Takahashi, M., Kobayashi, H., Mizutani, Y., Hara, A., Iida, T., Miyai, Y., Asai, N., & Enomoto, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.749924 · Cited by 46
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 45
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
Ware, M. B., Phillips, M., McQuinn, C. W., Zaidi, M. Y., Knochelmann, H. M., Greene, E. R., Robinson, B. S., Herting, C. J., Mace, T. A., Chen, Z., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.155006 · Cited by 44
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 48
Ben‐Shmuel, A., Gruper, Y., Halperin, C., Levi-Galibov, O., Rosenberg-Fogler, H., Barki, D., Carradori, G., Stein, Y., Yagel, G., Naumova, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0131 · Cited by 63
Mathematical model of chronic pancreatitis
Hao, W., Komar, H. M., Hart, P. A., Conwell, D. L., Lesinski, G. B., & Friedman, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620264114 · Cited by 43
Kibe, S., Ohuchida, K., Ando, Y., Takesue, S., Nakayama, H., Abe, T., Endo, S., Koikawa, K., Okumura, T., Iwamoto, C., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.12.005 · Cited by 49
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma
Liu, Z., Chen, M., Zhao, R., Huang, Y. C., Liu, F., Li, B., & Qin, Y. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz134 · Cited by 41
Cai, W., Sun, X., Jin, F., Xiao, D., Li, H., Sun, H., Wang, Y., Lu, Y., Liu, J., Huang, C., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.021 · Cited by 45
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 44
Magagna, I., Gourdin, N., Kieffer, Y., Licaj, M., Mhaidly, R., André, P., Morel, A., Vincent‐Salomon, A., Paturel, C., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13235878 · Cited by 48
Geleta, B., Shehadeh-Tout, F., Lim, S. C., Sahni, S., Jansson, P. J., Apte, M. V., Richardson, D. R., & Kovačević, Ž. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101608 · Cited by 40
Fibrous stroma: Driver and passenger in cancer development
Sharma, V., Letson, J., & Furuta, S. (2022) · Science Signaling · doi:10.1126/scisignal.abg3449 · Cited by 41
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.